Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells

Oncotarget

Volumn 8, Issue 5, 2017, Pages 7533-7539

  Liang, Ping ^a   Shi, Hongming ^a   Zhu, Weiguo ^a   Gui, Qunfeng ^a   Xu, Ya ^a   Meng, Jianfeng ^a   Guo, Xiaoyuan ^b   Gong, Zhuang ^c   Chen, Huaqun ^a  

^a The Sixth Affiliated Hospital of Nantong University   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Chemotherapy; Glioma cells; Silver nanoparticles (AgNPs); Temozolomide (TMZ)

Indexed keywords

SILVER NANOPARTICLE; TEMOZOLOMIDE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DACARBAZINE; METAL NANOPARTICLE; SILVER DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOSENSITIVITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; G2 PHASE CELL CYCLE CHECKPOINT; GLIOMA CELL; HUMAN; HUMAN CELL; PARTICLE SIZE; BRAIN TUMOR; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; GLIOMA; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; HUMANS; METAL NANOPARTICLES; SILVER COMPOUNDS; TEMOZOLOMIDE;

EID: 85018937268     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.13503     Document Type: Article

References (25)

1. Parney F, Chang SM. Current chemotherapy for glioblastoma. Cancer. 2003; 9:149-156
2. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002; 359:1011-1018
3. Nagane M, Levitzki A, Gazit A, Webster K. Cavenee, Su Huang HJ, Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA. 1998; 95:5724-5729
4. Reardon DA, Egorin MJ, Desjardins A, Vredenburgh JJ, Beumer JH, Lagattuta TF, Gururangan S, Herndon JE, Salvado AJ, Friedman HS. Phase I pharmacokinetic study of the vascularendothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma. Cancer. 2009; 115:2188-2198
5. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007; 2:751-760
6. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharmacol Res. 2006; 23: 1417-1450
7. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008; 7:771-782
8. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008; 83:761-769
9. Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biology. 2009; 10:65
10. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomaterialia. 2011; 7:347-354
11. Kim S, Choi JE, Choi J, Chung KH, Park K, YiJ. Ryu DY, Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicology in Vitro. 2009; 23: 1076-1084
12. Héctor RH, Salma JB, Pedro PMC, Eduardo GE, Humberto T, Mauricio T, Saber MH, Syed FA, Carmen G, Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicology Lett. 2009; 191:305-313
13. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ, The apoptotic effect of nanosilver is mediated by a ROS-and JNKdependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicology Lett. 2008; 179:130-139
14. Sanpui P, Chattopadhyay A, Ghosh SS, Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl Mater Interfaces. 2011; 3:218-228
15. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells.Toxicology and Applied Pharmacology. 2008; 233:404-410
16. Kalishwaralal K, Banumathi E, Ram KPS, Deepak V, Muniyandi J, Eom SH, Gurunathan S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells, Colloids and Surfaces B: Biointerfaces. 2009; 73:51-57
17. Sriram MI, Kanth SBM, Kalishwaralal K, Gurunathan S, Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Inter J Nanomedicine. 2010; 5:753-762
18. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009; 3:279-290
19. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352:997-1003
20. Lee PC, Meisel D, Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J Phys Chem. 1982; 86:3391-3395
21. Jeyaraj M, Sathishkumar G, Sivanandhan G. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B Biointerfaces. 2013; 106:86-92
22. Liu JH, Zhao YX, Guo QQ, Wang Z, Wang H, Yang Y, Huang Y, et al. TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials. 2012; 33: 6155-6161
23. Locatelli E, Naddaka M, Uboldi C, Loudos G, Fragogeorgi E, Molinari V, Pucci A, Tsotakos T, Psimadas D, Ponti J, Franchini MC, et al. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (Lond) 2014; 9:839-849
24. Sharma S, Chockalingam S, Sanpui P, Chattopadhyay A, Ghosh SS. Silver nanoparticles impregnated alginatechitosan-blended nanocarrier induces apoptosis in human glioblastoma cells. Adv Healthc Mater. 2014; 3:106-114
25. Liu PD, Huang ZH, Chen ZW, Xu R, Wu H, Zang F, Wang C, Gu N, et al. Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 2013; 5:11829-11836